In this clinical trial , @ liver transplant recipients were randomized to be monitored in real-time for HHV-@ and HHV-@ viremia by polymerase chain reaction at regular intervals from @ to @ weeks after transplantation ( `` monitoring '' group ) or to undergo usual care ( `` no-monitoring '' group ) .